Ipratropium Bromide Solution
Product Images NDC 64980-640

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide (NDC 64980-640). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

97e130d5-figure-01 (97e130d5 Figure 01)

Chemical structure diagram of ipratropium bromide monohydrate. The image shows the molecular arrangement including the quaternary ammonium group and bromide ion with water of hydration, alongside the molecular formula C20H30BrNO3·H2O and molecular weight 430.4.*

FDA Label Image

97e10d5-figure-02 (97e130d5 Figure 02)

An instructional line drawing showing a person using both hands to twist open a small ampule or vial, likely demonstrating how to access a liquid medication for inhalation.*

FDA Label Image

97e130d5-figure-03 (97e130d5 Figure 03)

An instructional illustration showing a hand inserting a small device or component into a larger medical device, possibly related to respiratory medication administration. The sketch highlights the positioning and insertion action.*

FDA Label Image

97e130d5-figure-04 (97e130d5 Figure 04)

An instructional illustration showing a person using a respiratory inhalation device. The image depicts the inhaler mouthpiece positioned at the lips, demonstrating the correct way to inhale the medication.*

FDA Label Image

F05 (Screenshot 2025 03 07 140115)

Label text for Ipratropium Bromide Inhalation Solution USP 0.02%, 0.5 mg/2.5 mL, indicating it is for oral inhalation only, not for injection. Contains 2.5 mL per vial with specified pH, storage conditions, and pharmacist instructions. Packaging includes 5 unit-dose vials.*

FDA Label Image

Figure 06 (Screenshot 2025 03 07 141620)

Packaging label for Ipratropium Bromide Inhalation Solution USP 0.02%, 0.5 mg/2.5 mL. The label indicates it is for oral inhalation only, not for injection, supplied in sterile unit-dose vials. The labeler is Rising Pharma Holdings, Inc., and the carton contains 25 x 2.5 mL vials. The NDC number 64980-640-02 is visible on the label.*

FDA Label Image

Figure 07 (Screenshot 2025 03 07 142042)

Packaging label for Ipratropium Bromide Inhalation Solution USP 0.02%, 0.5 mg/2.5 mL, by Rising Pharma Holdings, Inc. The label states the product is for oral inhalation only and not for injection, comes as sterile unit-dose vials with a carton containing 30 x 2.5 mL vials. The label includes usage and storage instructions along with barcode and regulatory text.*

FDA Label Image

Figure 08 (Screenshot 2025 03 07 142840)

Packaging label for Ipratropium Bromide Inhalation Solution USP 0.02%, strength 0.5 mg/2.5 mL, supplied in unit-dose vials. The label states it is for oral inhalation only and not for injection, with a carton containing 60 vials. The labeler is Rising Pharma Holdings, Inc., and the NDC is 64980-640.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.